INTRODUCTION
Specific antigen recognition is a hallmark of the adaptive immune response provided by antigen-specific B and T lymphocytes. Lymphocytes orchestrate a defense against pathogens, but they also actively maintain tolerance to self-antigens or innocuous exogenous antigens. FOXP3+ regulatory T cells (Tregs) represent a molecularly defined immunosuppressive T lymphocyte lineage that is essential for tolerance, as evidenced by the development of multi-organ autoimmunity in FOXP3-deficient humans and mice (Rudensky, 2011; Sakaguchi et al., 2008) . Another hallmark of FOXP3 deficiency or dysfunction is the neonatal development of severe allergies resulting from dysregulated T helper cell type 2 (Th2) responses (Barzaghi et al., 2012; Josefowicz et al., 2012; Kabat et al., 2016) , demonstrating that Tregs are also required to maintain tolerance against innocuous environmental antigens at mucosal surfaces. Indeed, allergy development due to Treg instability (Kabat et al., 2016; Wan and Flavell, 2007) or defective Th2 regulation has been reported in mice (Jin et al., 2013; Joller et al., 2014; Ulges et al., 2015; Zheng et al., 2009 ) and is also discussed in human allergy (Ling et al., 2004) .
However, in contrast to the broad neonatal allergies observed in FOXP3-deficient patients and mice, most allergic patients develop disease only against a limited number of allergenic proteins, whereas tolerance is maintained against the vast number of non-allergenic proteins contained in airborne particles, such as pollen, spores, or house dust mites. How such an antigenspecific loss of tolerance develops and, in particular, whether this is regulated via Treg antigen specificity is not understood. Indeed, human Treg target antigens relevant for mucosal tolerance are currently unknown (Gratz and Campbell, 2014) . It has been demonstrated in mice that Treg specificity is biased toward the recognition of autoantigens (Hsieh et al., 2004; Kieback et al., 2016; Legoux et al., 2015; Malhotra et al., 2016) and that Tregs require continuous T cell receptor (TCR) stimulation, presumably H3  H4  H5  H8  H9  H3  H4  H5  H8  H9   CD137+ CD154+ -3.0 +3.0 
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by self-antigens, to suppress autoimmunity (Levine et al., 2014; Vahl et al., 2014) . However, Tregs specific for exogenous antigens have been detected in naive (Moon et al., 2011; Zhao et al., 2011) and pathogen-infected mice (Shafiani et al., 2013; Suffia et al., 2006; Zhao et al., 2011) and humans (Bacher et al., 2014a; Ebinuma et al., 2008; Vukmanovic-Stejic et al., 2013) . Furthermore, Tregs specific for commensal microbiota were found in murine intestinal tissues (Cebula et al., 2013; Lathrop et al., 2011) , and murine Tregs against fetal antigens promote tolerance during pregnancy (Rowe et al., 2012; Samstein et al., 2012) . This demonstrates that Tregs are not an exclusively self-reactive population. However, evidence for a dominant role of specific FOXP3+ Tregs in tolerance against aeroantigens is missing. Direct analysis of allergen-specific T cells from healthy and allergic patients revealed rather an altered balance of conventional T cell (Tcon) subsets, such as Th2 versus Th1 or interleukin (IL)-10-producing type-1 regulatory T cells (Tr1) (Meiler et al., 2008; Van Overtvelt et al., 2008; Wambre et al., 2012) . So far, technical limitations have prevented the direct identification of antigen-specific Tregs in humans (Bacher and Scheffold, 2015) . Therefore, it is presently unknown whether aeroantigens elicit antigen-specific Treg responses and how Treg antigen specificity versus Treg functionality impacts allergen-specific loss of tolerance in humans.
Here, we used a recently developed technology ''antigenreactive T cell enrichment'' (ARTE) for a comprehensive characterization of human Treg responses against exogenous antigens to define the role of Treg antigen specificity for the regulation of mucosal tolerance.
RESULTS
High Frequencies of Antigen-Specific Tregs against Aeroantigens So far, Treg antigen specificities in physiological repertoires have escaped detailed analysis due to the low frequency of individual clones and a lack of specific detection tools (Bacher and Scheffold, 2015) . We recently overcame this difficulty by combining in vitro stimulation of human peripheral blood mononuclear cells (PBMCs) with antigens and subsequent magnetic enrichment of the rare antigen-activated T cells (antigen-reactive T cell enrichment, ARTE) (Bacher et al., 2013 (Bacher et al., , 2014a . ARTE relies on the divergent expression of the activation markers CD137 (4-1BB) on Tregs and CD154 (CD40L) on Tcons after 7 hr of antigen activation ( Figures 1A and 1B) (Bacher et al., 2014a; Schoenbrunn et al., 2012) . Even complex antigens or undefined protein mixtures that are naturally processed by the autologous antigen-presenting cells (APCs) can be used for stimulation. However, variable abundance or processing of individual proteins may affect detection of certain specificities.
Magnetic enrichment allows rapid processing of large cell samples (10 7 -10 9 ) and thus the collection of a sufficiently large population of target cells for direct and in-depth characterization of antigen-specific Tcons and Tregs occurring at frequencies of 1 cell within 10 5 -10 6 CD4+ T cells (Bacher et al., 2013 (Bacher et al., , 2014a .
To identify physiological target antigens of human Tregs, we screened a panel of tolerogenic (food, commensal microbes, pollen) and immunogenic (infectious microbes, vaccines) candidate antigens for Treg versus Tcon reactivity using ARTE. Following 7 hr of stimulation with whole-antigen lysates, antigen-reactive Tregs (CD137+) and Tcons (CD154+) were isolated from R10
7 PBMCs. Interestingly, we found considerable frequencies of Tregs (0.003%-0.29%, mean 0.030% within CD4+ T cells) against the human pathogens Candida albicans, Staphylococcus aureus, cytomegalovirus (CMV), and influenza A virus ( Figure 1C ). This demonstrates that pathogen-specific Tregs can be an inherent part of the physiological human pathogen-specific T cell response, which has been reported before for experimental infection models (Shafiani et al., 2013; Suffia et al., 2006; Zhao et al., 2011) . Remarkably, we observed similarly high frequencies of antigen-specific Tregs against antigen lysates derived from innocuous environmental aeroantigens, such as plant pollen, house dust mites, or airborne fungi (Aspergillus fumigatus) (range 0.002%-0.34%, mean 0.026% within CD4+ T cells) ( Figures 1C and 1D ). By contrast, Tregs specific for other tolerogenic candidate antigens, such as food or commensal bacteria, were rare and/or highly variable among different donors. Treg identity was confirmed at the molecular and epigenetic level. Gene expression profiling of sorted A. fumigatus-specific CD137+ Tregs and CD154+ Tcons from five healthy donors ( Figure 1E ) revealed expression of Treg marker genes, such as FOXP3, IL2RA (CD25), HELIOS, CTLA4, TIGIT, ENTPD1 (CD39), GARP, and a lack of CD127 and IL-2 as well as of effector cytokines. These results were confirmed at the protein level by flow-cytometric analysis ( Figure 1B ; Figure S1 ). In addition, >80% of the CD137+ Tregs showed a complete demethylation of the Treg-specific demethylated region (TSDR) at the FOXP3 gene locus ( Figure 1F ), indicating a stable Treg phenotype (Baron et al., 2007) . Importantly, all aeroantigen-specific Tregs displayed a CD45RO+ memory phenotype ( Figure 1G ) and were absent in cord blood ( Figure 1H ), indicating their specific expansion in response to an antigen in the periphery. Individual T cells and their progeny can be identified via their unique T cell receptor (TCR) sequence. Thus, TCR sequence comparison based on next-generation sequencing allows the determination of clonal relations between certain subsets. TCR-b chain repertoire analysis of 10 4 fluorescence-activated cell-sorted (FACS) antigenspecific CD137+ Tregs revealed almost no overlapping TCRs with CD154+ memory Tcons (Tmems) ( Figure 1I , similarity (I and J) TCR-b sequence comparison of (I) antigen-specific Tmems versus Tregs and (J) duplicate-sorted A. fumigatus-specific Tmems and Tregs. Symbols outside the lines represent sequences found in one sample only. Linear regression and Yue-Clayton similarity index (S YC ) considering the proportion of each sequence in the respective sample are indicated (0 is total dissimilarity, 1 is identical populations). Data are representative of five (I) or two (J) donors from two independent sorting experiments. Each symbol of (C), (D), (F) Figure 1J indicates the overlap between the respective duplicate-sorted antigen-specific Tregs (S YC = 0.29) and Tmems (S YC = 0.37).
Transcriptional profiling and flow-cytometric analysis revealed strong upregulation of the chemokine receptors CCR4, CCR5, CCR6, and CXCR6 on aeroantigen-specific CD137+ Tregs, which have been reported to enable T cell migration to the lung tissue (Lee et al., 2011; Mikhak et al., 2013; Thomas et al., 2007) (Figure 1E ; Figure S2 ). To confirm the specificity of the identified aeroantigen-reactive Tregs, sorted CD137+ Tregs and CD154+ Tcons were expanded and revealed high specificity following restimulation with their antigen in the presence of autologous APCs (Figures S3A-S3D) . Treg cross-reactivity was detected between birch and grass pollen probably due to homologous proteins, as it was reported for Tcon responses before (Burastero et al., 2004) . Furthermore, ex vivo CD154 and CD137 induction was inhibited by blocking antigen presentation via addition of an human leukocyte antigen (HLA)-DR antibody during stimulation with the antigen lysates ( Figure S3E ). Finally, in an in vitro functional assay, expanded antigen-specific CD137+ Tregs showed a strong antigen-specific suppressive capacity ( Figure S3F ).
Taken together, we identified considerable frequencies of clonally expanded Tregs with specificities for various exogenous antigens in human peripheral blood, which display all molecular, phenotypic, and functional features of stable Tregs. Remarkably, among the tolerogenic candidate antigens, particularly aeroantigens, elicited a strong Treg response, although we cannot exclude that food or commensal-specific Tregs are locally trapped within the intestinal tissues (Cebula et al., 2013; Lathrop et al., 2011) rather than circulating in peripheral blood. Overall, these data suggest that antigen uptake via the lungs is an important route for the induction of antigen-specific Treg responses in humans.
Tregs Specific for Aeroantigens Control Tcon Responses in Healthy Donors
To determine the overall T helper cell response for a given antigen, corresponding to states of tolerance or immunity, we next quantified the corresponding Tcon response in healthy donors. Tcons specific for pathogens displayed the expected memory and/or effector phenotype ( Figure 2A ) and occurred at higher frequencies than the corresponding Tregs ( Figures S4A-S4D ), resulting in a low Treg to Tmem ratio (Treg/Tmem ratio < 1) (Figures 2B and 2C) . This supports the concept of a co-expansion of effector-and regulatory T cells during the immune reaction against pathogens to limit immunopathology. In stark contrast, a substantial fraction of aeroantigen-specific Tcons displayed a naive phenotype, as evidenced by a lack of CD45RO expression, but high expression of CCR7 (Figure 2A ), CD45RA, CD27, and CD31 and lack of CD95, CD11a, and effector cytokine expression ( Figures S4E-S4G ). In concordance, the frequency of Tregs against aeroantigens clearly exceeded the frequency of the corresponding Tmem in the majority of donors (Treg/ Tmem ratio > 1) (Figures 2B and 2C) , indicating a dominant tolerogenic response. To corroborate this finding, we further dissected the antigen-specific Tmem compartment. TCR-b chain sequencing of sorted aeroantigen-specific (Birch) Tmems revealed no major clonal expansion, depicted by the overall high diversity (horizontal shape of the Ré nyi diversity profile; Figure 2D) and an even distribution of TCR-b sequences (low values of the Gini-coefficient) ( Figure 2E ). In contrast, oligoclonal expansions were present in the Tregs as well as in the pathogenspecific (C. albicans) Tmem compartment, indicated by the s-shaped Ré nyi profile ( Figure 2D ) and an increased Gini-coefficient ( Figure 2E ). Furthermore, in vitro-expanded aeroantigenspecific Tmem cells displayed 2-3 log lower functional avidity as compared to the corresponding Tregs ( Figure 2F ). Also, chemokine receptors relevant for lung homing, which were uniformly expressed by Tregs, were virtually absent on the corresponding Tmems ( Figure S2 ).
Finally, we asked whether Tregs also dominate the in vivo response to antigen. Therefore, we analyzed ex vivo Ki-67 expression of birch-specific T cells to identify cells that have recently proliferated in vivo in the presence (within allergen season) and absence of in vivo antigen exposure (outside allergen season). Birch-specific Tregs revealed marginal proliferative activity outside the season (0.1%-8.5%, mean 5.6% from September to February) which increased (4.8%-20%, mean 11%) between March and May, indicating that these cells are actively dividing during the birch pollen season ( Figure 2G ). In contrast, for perennial A. fumigatus antigens, no seasonal influence on Ki-67 expression of specific Tregs was observed. Furthermore, in sharp contrast to birch-specific Tregs, Ki-67+ cells were absent among the birch-and A. fumigatus-specific Tcons at all times ( Figure 2G) .
Collectively, these data show that antigen-experienced, clonally expanded, and high-avidity-selected Tregs dominate the antigen-specific response against harmless environmental aeroantigens in humans. This strong Treg response seems to mark a true state of antigen-specific tolerance, since the corresponding Tcons lack the typical characteristics of in vivo antigen-primed effector and/or memory T cells and are indeed excluded from the immune response to antigen in vivo.
Tcons, but Not Tregs, Are Altered in Allergic Humans Having identified Tregs as the major T cell population against aeroantigens, we analyzed whether antigen-specific Treg responses are quantitatively or qualitatively altered in allergic individuals, which could explain their failure to control allergy development. Birch-allergic donors were clearly distinguished from healthy individuals on the basis of increased Th2 cytokine production by birch-pollen-specific Tcons ( Figures 3A and 3B) , correlating with birch-specific immunoglobulin E (IgE) levels ( Figures S5A and SB) . Furthermore, birch-specific Tcons from allergic donors showed a significantly increased proportion and absolute number of Tmems ( Figures 3C and 3D ) as well as phenotypic markers of Th2 cells on a transcriptional and protein level (Figures 3E and 3F; Figures S5C and S5D) and lung homing chemokine receptor expression ( Figure 3F ). TCR-b chain repertoire analysis depicted oligoclonal expansion of birch-specific Tmems ( Figure 3G ), and Th2-derived cell clones showed 2-3 log higher functional avidity as compared to healthy donors (Figure 3H; Figures S5G and S5H) . In summary, these data confirm a clear functional differentiation of birch-specific Tcons in allergic donors.
However, in stark contrast, we did not observe any difference of the birch-specific Treg response in allergic versus healthy donors. Neither Treg frequencies ( Figure 4A ) nor the phenotypic Treg characteristics were affected (Figure 4B; Figures S5E and S5F) . In vitro functional assays also confirmed the strong antigen-specific suppressive activity of expanded CD137+ Tregs from allergic donors ( Figure 4C ). We further observed no differences in the TCR-b chain repertoire ( Figure 4D ) or the functional avidity ( Figure 4E ) of the birch-specific Tregs between healthy versus allergic donors.
Thus, in allergic donors, antigen-specific Th2 responses develop despite the presence of a quantitatively and qualitatively normal Treg compartment, thereby decreasing the ratio of Tregs/Tmems to values %1 ( Figure 4F ). This escape of birchspecific Th2 cells from Treg-mediated control was also detected in vivo, because birch-specific Tmems from allergic donors displayed strongly increased Ki-67 expression during allergen season compared to healthy donors ( Figure 4G ). In addition, the frequencies of Ki-67+ birch-specific Tregs were also increased in allergic donors ( Figure 4G ), supporting that birch-specific Tregs are not functionally impaired per se. Changes in the Treg/Tmem ratio inside and outside the season were only observed in healthy donors ( Figure S5I ), demonstrating that, in allergic individuals, both populations are equally activated by the presence of antigen.
Tregs and Th2 Cells Target Different Proteins
Because Treg responses were not altered in allergic donors when whole protein extracts were used for stimulation, we hypothesized that the apparent lack of Treg-mediated Th2 control might be due to differing target antigens. Aeroantigens are typically inhaled as particles, such as intact pollen or fungal spores, containing multiple proteins (Platts-Mills and Woodfolk, 2011) . However, the allergic response is mostly directed against very few immune-dominant allergens . This means that the sample with the highest value at a = 0 has the highest richness, but the lower value at a = infinite indicates a higher proportion of the most abundant sequence, i.e. lower population diversity. A sample with a profile that is overall higher than the profiles of other samples is therefore more diverse, and an s-shaped versus a more horizontal curve shape indicates less evenness, i.e. more clonal expansion. (E) Gini coefficient depicting the distribution of TCR-b sequences (0 is total equality, i.e., all clones have the same proportion, 1 is total inequality, i.e. a population dominated by a single clone).
(F) Expanded birch-specific cells were restimulated with increasing antigen concentrations. EC 50 values were calculated from dose-response curves (naive T cells [Tnaive] n = 6; Tmems n = 9, Tregs n = 10; two to three independent experiments). (G) Seasonal timeline of Ki-67 expression in healthy donors. Each symbol in (B), (C), (F) , and (G) represents one donor. Horizontal bars, geometric mean (B and F), mean (C and G). Statistical differences, one-way ANOVA with Tukey post hoc test (C and G), twotailed unpaired Mann-Whitney test (F) . See also Figure S4 .
donors, whereas others activated Tregs only in a subgroup of donors. However, in those donors with detectable Tregs against individual proteins, the frequencies of specific Tregs were in a similar range. These data suggest that, although all proteins can, in principle, induce Treg responses, they differ considerably in their Treg-activating potential, depicted as the percentage of healthy donors with detectable Tregs against that protein (Figure 5B) . Interestingly, ranking proteins according to their Tregactivating potential revealed that known allergens (indicated in red in Figure 5B ), including the major birch and grass allergens Bet v1, Phl p1, and Phl p5, possess rather low Treg response rates compared to minor allergens or non-allergenic proteins, which activate Tregs in the majority of donors. Importantly, the absence of specific Tregs does not lead to allergy per se, because several healthy donors also lack Tregs specific for nominal allergens as well as some other non-allergenic proteins, such as PST-1 or GliT. Thus, the absence of specific Tregs may pro- Each symbol in (A) and (E)- (G) represents one donor. Horizontal bars, mean (A and G) , geometric mean (E and F) . Statistical differences, two-tailed unpaired Mann-Whitney test (A and E-G) . See also Figure S5 .
vide a window of opportunity for subsequent Th2 development, which is prevented in the presence of Treg. To test this hypothesis of antigen-specific Treg-mediated protection from Th2 development, we directly analyzed whether Treg and Th2 responses against the same protein co-exists in individual healthy and allergic donors. Figure 5C shows the cumulative data from a cohort of healthy and allergic donors. Normalized frequencies of Th2 and Tregs against individual proteins from individual donors are plotted against each other (total data points n = 270). This side-byside comparison indeed identifies a striking exclusivity of antigen-specific Treg versus Th2 responses. In fact, specific Th2 responses against a particular protein are only observed when Tregs reactive to the same protein are either completely lacking or their frequency is very low ( Figure 5C ). These data suggest that Tregs prevent development of Th2 responses in a highly antigen-specific manner and that the Treg-activating potential of an individual protein is a critical determinant of its allergenic potential.
Next, we wondered which protein characteristics impact the induction of Treg responses. To date, no unique allergendefining feature has been identified, but, interestingly, all allergens are small (10-50 kDa), stable, and highly water-soluble proteins, resulting in their rapid release from airborne particles following uptake into the lung (Platts-Mills and Woodfolk, 2011) . Such a physical separation of soluble and particle-associated antigens may lead to uptake by different antigen-presenting cells and eventually to different T cell responses. We therefore analyzed the Treg response against the particle-associated or soluble fractions of birch pollen. Crude extracts of soluble and particle-associated proteins were generated by 5 hr of waterincubation of birch pollen grains. The soluble protein fraction consisted primarily of small proteins as compared to the particle-associated fraction ( Figure 5D ). Strikingly, the particle-associated fraction generated strong and uniform Treg responses in all healthy and allergic donors ( Figure 5E ). In contrast, the Treg response against the soluble protein fraction was highly heterogeneous and significantly lower compared to the particle-associated fraction, reflecting the data obtained with the single proteins ( Figure 5A ). Th2 cytokine production in allergic donors was mainly observed in response to the soluble lysate ( Figure 5F ), confirming the presence of the dominant allergens. In line with that, the Tmem response against the soluble fraction strongly increased in allergic versus healthy donors ( Figure 5G ). The disparate targeting of individual proteins by Tregs versus Th2 cells for soluble, but not particle-associated, proteins in allergic donors is further illustrated by the strong and selective drop of the Treg/Tmem ratio against the soluble proteins ( Figure 5H ). These data suggest that particle-associated proteins effectively induce Treg responses and that these antigen-specific Tregs prevent Th2 and allergy development against particle-associated, but not soluble, proteins. In contrast, rapid protein dissociation from particles following uptake into the lung reduces the ability to induce Treg responses and conversely provides a window of opportunity for the development of Th2 responses and allergy. (E) Soluble and particle lysate-specific Treg frequencies (healthy n = 19, allergic n = 10; five independent experiments).
(F) Cytokine expression of soluble or particle lysate-stimulated CD154+ Tcons from allergic donors (n = 10). (G) Soluble and particle lysate-specific Tmem frequencies (healthy n = 19, allergic n = 10). (H) Ratio of birch-specific memory Tregs/Tmems (healthy n = 19, allergic n = 10). Horizontal bars, median (A), geometric mean (E, G, and H) . Statistical differences, two-tailed paired t test (E and F) , two-tailed unpaired t test (G and H) of log 10 transformed (E, G, and H), or linear (F) values. See also Figure S5 .
DISCUSSION
The antigen-specificity of human Tregs is still largely unknown, preventing analysis of fundamental aspects of Treg biology, such as antigen-specific tolerance, antigen-induced functional differentiation, and spatial distribution or memory. This limits our understanding of the role of Tregs for human immune pathologies and the development of Treg-based treatment strategies. The methodological approach introduced here provides a universal basis to directly address the aspect of Treg specificity in humans. Our work specifically highlights the role of antigen-specific Tregs for the regulation of tolerance versus allergy against aeroantigens.
The simultaneous quantification and characterization of antigen-specific Tregs and Tcons allows the study of their interplay and the definition of their mutual contributions to anti-pathogen immune responses as well as to states of active or passive tolerance. This led to the unexpected identification of a robust population of Tregs specific for innocuous aeroantigens that are present in all donors and feature molecular, phenotypic, and functional characteristics of peripherally expanded stable Tregs. Aeroantigen-specific Tregs seem to actively maintain tolerance, because a corresponding clonally expanded highavidity-selected Tcon response was absent in healthy donors.
The identification of Tregs as dominant mediators of tolerance against aeroantigens is at odds with the current view of tolerance as a balanced Tcon response of protective IL-10/Tr1 versus pathogenic Th2 cells (Meiler et al., 2008; Van Overtvelt et al., 2008; Wambre et al., 2012) . However, previous analyses have focused only on major allergenic proteins, whereas the large variety of non-allergenic proteins, which we identify here as main Treg targets, has been ignored. Indeed, major histocompatibility complex (MHC) multimers loaded with major Th2 target peptides have failed to identify dominant populations of allergen-specific Tregs in human blood (Palomares et al., 2011; Van Overtvelt et al., 2008; Wambre et al., 2012) . In contrast, our finding of distinct protein specificities of Tregs versus Th2 cells in individual donors strongly suggests that if antigen-specific Treg responses are induced, they efficiently suppress Th2 development. In this way, Treg specificity would play a major role in restricting the repertoire of potential allergens to those proteins that fail to activate Treg responses. Together with the fact that Tregs from allergic donors were indistinguishable from healthy controls, these data also strongly argue against the idea of a generally impaired Treg response in allergic patients (Jin et al., 2013; Joller et al., 2014; Kabat et al., 2016; Ling et al., 2004; Soyer et al., 2013; Ulges et al., 2015; Wan and Flavell, 2007; Zheng et al., 2009 ). Although we cannot directly prove that human antigen-specific Tregs specifically suppress Th2 induction in humans, there is ample evidence from animal models for antigen-specific Th2 suppression by Tregs (Duan et al., 2011; Girtsman et al., 2010; Kearley et al., 2005 ). An alternative explanation to active Treg-mediated suppression would be that allergenspecific Tregs are selectively trapped in the respiratory tissues and are therefore not found in blood. However, we consider this unlikely, because Tregs against major allergens were present in the blood but were strictly absent in those allergic donors with detectable Th2 cells against the very same allergen ( Figure 5C ). Furthermore, recent studies in mice clearly show that Tregs with specificities for locally expressed model antigens are always detected in the periphery, despite local accumulation in tissues, including lung (Kieback et al., 2016; Legoux et al., 2015; Malhotra et al., 2016) . Nevertheless, understanding the molecular and cellular details of Treg-mediated regulation in local tissues will be a major task for future studies.
Furthermore, our data reveal that allergens belong to a larger group of pollen-or spore-derived proteins, which have a generally diminished ability to induce Treg responses, resulting in a low incidence of antigen-specific Tregs against these proteins already in healthy donors. However, this also shows that the absence of specific Tregs does not lead to Th2 development per se. Instead, we propose that allergen-specific Th2 development is controlled at two independent checkpoints. The dominant immune reaction to inhaled preferentially particle-associated antigens is antigen-specific Treg-mediated tolerance. Antigens escaping this first checkpoint primarily seem to be ignored by the immune system, as suggested by the absence of clonally expanded antigen-specific Tcons in healthy donors. Proteins that fail to induce specific Treg responses but remain associated with the inhaled particle may be protected by Tregmediated bystander suppression acting locally on the APCs, which take up and present all particle-associated antigens (Thornton and Shevach, 2000) . In contrast, proteins that rapidly dissociate from inhaled particles also would escape Treg-mediated bystander suppression and thus would maintain allergenic potential. However, the Th2-inducing factors relevant at this second checkpoint are still not fully understood but would depend on additional risk factors, such as known protein-intrinsic, environmental, or genetic parameters.
Our findings have important clinical implications since they highlight the need to induce allergen-specific Treg responses rather than rely on strategies aimed at activating the existing Treg pool. To this end, our data suggest that the lung is a particularly promising antigen-targeting site for the induction of Treg responses (Soroosh et al., 2013) , especially when considering the high Treg frequencies induced by minute quantities of inhaled antigens, estimated to be as little as 1 mg pollen protein per year (Platts-Mills and Woodfolk, 2011). Modification of the antigen formulation, such as stable integration into aerosolized particles, might represent a simple strategy to increase Treg induction upon lung targeting. Defining the physicochemical properties of inhaled antigens relevant for Treg activation or induction in vivo and establishing animal models mimicking human exposure to such environmental antigens will be important tasks for future studies. The ability to monitor antigen-specific Treg responses directly in humans, as demonstrated here, will facilitate subsequent translation into Treg-based therapeutic strategies.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: A. fumigatus mycelial lysate and recombinant proteins were generated as described (Bacher et al., 2014b) . For generation of bacteria lysates, bacteria were grown on solid media (Columbia Blood Agar/ Biomé rieux, Marcy l'Etoile France), harvested by scraping into 17.4 mL distilled water and lysed by addition of 0.4 mL NaOH (1N), 0.2 mL HCl (2N) and 2 mL 10 x PBS (pH 7.5). Lysis of cells was confirmed by microscopical analysis and by negative culture of lysates.
For generation of soluble and particle birch lysates, 180 mg whole birch pollen grains (Betula pendula; Allergon, Ä ngelholm, Sweden) were shaken for 5 hr in 1ml sterile water. After centrifugation for 10 min at 10.000 3 g, the supernatant was taken as soluble lysate. The remaining pellet was disrupted using the GentleMACS device (Miltenyi Biotec) program RNA.01 (5 times). The lysate was centrifuged for 10 min at 400 3 g to remove non-disrupted birch pollen grains and supernatant was taken as particle lysate.
Recombinant Bet v6 was produced in E. coli and purified from the soluble fraction of the bacterial lysate using a 5ml Q FF anion exchange chromatography column (GE Healthcare). The protein remained in the unbound fraction and was further purified by hydrophobic interaction chromatography with a 5 mL phenyl FF column (GE Healthcare).
Flow Cytometry
Cells were stained in different combinations of fluorochrome-conjugated antibodies (see Key Resources Table) . Viobility 405/520 Fixable Dye (Miltenyi Biotec) was used to exclude dead cells. For intracellular staining cells were fixed and permeabilized with the Inside Stain Kit (Miltenyi Biotec). Staining for FOXP3, Ki-67, CTLA-4 and HELIOS was performed using the Foxp3 Staining buffer Set (Miltenyi Biotec). Data were acquired on a MACSQuant Analyzer 10 (Miltenyi Biotec), or LSR Fortessa (BD Bioscience, San Jose, CA, USA) and MACSQuantify (Miltenyi Biotec) or FlowJo (Treestar, Ashland, OR, USA) software was used for analysis.
In vitro T cell expansion and restimulation
Purified CD154+ Tcons or IL-4 producers in Figure S5 (IL-4 Secretion Assay Cell Enrichment and Detection Kit, Miltenyi Biotec) were expanded in presence of 1:100 irradiated feeder cells in TexMACS medium (Miltenyi Biotec), supplemented with 5% (v/v) human ABserum (GemCell), 200 U/ml IL-2 (Proleukinâ; Novartis, Nü rnberg, Germany), and 100 IU/ml penicillin, 100 mg/ml streptomycin, 0.25 mg/ml amphotericin B (Antibiotic Antimycotic Solution, Sigma Aldrich) (from now on referred to as ''expansion medium'') at a density of 2.5 3 10 6 cells/cm 2 . During expansion for 2-3 weeks, medium was replenished and cells were split as needed. Antigen-specific T cell clones were generated by single cell sorting of CD154+ T cells into 96-well round bottom plates with 1 3 10 5 / well irradiated autologous feeder cells in expansion medium, supplemented with 10% AB-serum and additionally 20 mM b-Mercaptoethanol (GIBCO, Life Technologies), 2 mM glutamine and 30 ng/ml anti CD3 (OKT-3; Miltenyi Biotec). After 7 days, 100 ml medium was replenished and 1 3 10 5 irradiated feeder cells were added. For Treg cell lines, 1 3 10 4 /well purified CD137+ cells were cultured in 96-well round-bottom plates in expansion medium, supplemented with 400 IU/ml IL-2 and additionally 30 nM rapamycin (Sigma Aldrich). Cells were expanded for 21 days, medium was replenished every 2-3 days.
For restimulation, fastDCs were generated from autologous CD14+ MACS isolated monocytes (CD14 MicroBeads; Miltenyi Biotec) by cultivation in X-Vivo15 medium (BioWhittaker/Lonza), supplemented with 1000 IU/ml GM-CSF and 400 IU/ml IL-4 (both Miltenyi Biotec). Before restimulation expanded T cells were rested in RPMI-1640 + 5% human AB-serum for 2 days. 1 3 10 5 expanded T cells were restimulated in a ratio of 1:1 with antigen-loaded fastDCs in 384-well flat bottom plates for 7 hr, with 1 mg/ml Brefeldin A (Sigma Aldrich) added for the last 4 hr.
In vitro proliferation assay Isolated CD4+ responder T cells (Tresps) (CD4 + T cell Isolation Kit, Miltenyi Biotec) were labeled with the CellTrace Violet Cell Proliferation Kit (Invitrogen, Molecular Probes â , Eugene, OR, USA). 1 3 10 5 Tresps were co-cultured in different ratios with antigen-specific Tregs and 2 3 10 5 Treg-autologous CD3-depleted (CD3 MicroBeads; Miltenyi Biotec) PBMCs as APCs and inducer of an alloreaction. Tregs were either stimulated specifically with their antigen or polyclonal with anti-CD3/CD28 beads (Treg Suppression Inspector; Miltenyi Biotec). On day 6, dilution of proliferation dye was analyzed by flow cytometry. Tresps could be discriminated from Tregs and APCs by using donors with opposite HLA-A2 expression.
Gel electrophoresis
Protein lysates were separated on a 4%-20% Tris-Glycine Gel (Anamed, Groß-Bieberau, Germany) by SDS-PAGE. Proteins were visualized by staining with Imperial Protein Stain Reagent (Thermo Fisher Scientific, Waltham, MA, USA).
FOXP3 TSDR methylation analysis 0.5-1 3 10 4 antigen-specific CD154+ and CD137+ CD4+ T cells were FACS purified. Genomic DNA was isolated using the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) and bisulfite treated (EpiTect, QIAGEN). Real time-PCR was performed in a final reaction volume of 20 ml containing 10 ml FastStart Universal Probe Master (ROX) (Roche Diagnostics, Mannheim, Germany), 50 ng/ml Lambda DNA (New England Biolabs, Frankfurt, Germany), 5 pmol/ml methylation or non-methylation specific probe, 30 pmol/ml methylation or non-methylation specific primers and 60 ng bisulfite-treated DNA or respective amount of plasmid standard. The samples were analyzed in triplicates on an ABI 7500 Cycler. Percent FOXP3 TSDR content was calculated by dividing the non-methylated copy number by the total genomic FOXP3 copy number.
TCR sequencing and data analysis NGS-based TCR repertoire analysis Genomic DNA was isolated from FACS purified 0.5-1 3 10 4 antigen-specific CD154+ and CD137+ CD4+ T cells using the AllPrep DNA/RNA Micro Kit (QIAGEN). Recombined TCR-b locus was amplified as previously described (Dziubianau et al., 2013) . Sequencing library preparation with consequent sequencing was performed using Illumina MiSeq Technology at NGS core facility at Berlin Brandenburger Center for Regenerative Therapies, Berlin, Germany. Reads with an average quality score below 30 were excluded from the analysis. The remaining high quality reads were processed using IMSEQ (Kuchenbecker et al., 2015) . Each clonotype was assigned an ID including Vb -and Jb-gene identity as well as CDR3 amino acid sequence. Equal clonotypes were clustered and further analyzed.
Data analysis
The similarity of two populations was determined by the Yue-Clayton similarity index (Yue et al., 2001) , which considers the proportion of each sequence in each population. The index is given by:
where n PQ is the the total number of sequences in the two populations P and Q; p i is the proportion of the i th sequence in population P; q i is the proportion of the i th sequence in population Q. The index ranges from 0 to 1, where 0 is total dissimilarity and 1 is identical populations. Linear regression was analyzed on log 10 transformed frequencies, only sequences shared between the two groups were used for calculation and only if the two groups shared more than four sequences. Clonal diversities of the TCR-b repertoires were evaluated for the top 50 expanded clones using Ré nyi diversity profiles (Ré nyi, 1961):
where H a is the entropy; n is the total number of unique sequences; p i is the proportion of the i th sequence and a a scaling parameter. By varying the a parameter, different diversity indices are calculated, such as the logarithm to the reciprocal Simpson diversity index at a = 2. At a = 1 the Ré nyi diversity is approximated by the Shannon diversity index. At a = 0 and a = infinite, the profiles provide the logarithm of richness and the logarithm of the reciprocal to the proportion of the most abundant sequence (Berger-Parker Index), respectively. This means that the sample with the highest value at a = 0 has the highest richness, but that the lower value at a = infinite indicates higher proportion of the most abundant sequence. A sample with a profile that is overall higher than the profiles of other samples is more diverse. Conversely, if the profiles cross at one point no ranking in diversity can be performed.
The equality of the distribution of TCR-b sequences was calculated for the top 50 expanded clones using the Gini coefficient (Sadras and Bongiovanni, 2004):
where x i is the abundance of the i th sequence, ranked in ascending order according to abundance and n is the total number of unique sequences. The coefficient ranges from 0 to 1, where 0 is total equality, i.e., all clones have the same proportion and 1 is total inequality, i.e., a population dominated by a single clone.
Microarray analysis Sample preparation
For the generation of amplified cDNA (SuperAmp Service, Miltenyi Biotec), 4000 FACS purified antigen-specific CD154+ and CD137+ CD4+ T cells were lysed in SuperAmp lysis buffer (Miltenyi Biotec), the mRNA was extracted using magnetic beads and transcribed into cDNA using tagged random and oligo(dT) primer. First strand cDNA was 5 0 tagged using a terminal deoxynucleotidyl transferase (Fisher Scientific) and globally amplified (Expand Long Template PCR System DNA Pol Mix; Roche) using primer complementary to the tag sequence. 250 ng of purified PCR product was labeled with Cy3-dCTP (Fisher Scientific) in a Klenow Fragment reaction (10 U) (Fisher Scientific).
Hybridization of Agilent Whole Human Genome Oligo Microarrays
The hybridization was performed according to the ''One-Color Microarray-Based Gene Expression Analysis'' protocol (part number G4140-90040) using the Agilent Gene Expression Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA). Briefly, 0.5 mg Cy3-labeled cDNAs were hybridized overnight to Agilent Whole Human Genome Oligo Microarrays 8x60K v2 (AMADID 039494; Agilent Technologies) using Agilent's recommended hybridization chamber and oven. Subsequently, microarrays were washed using the Agilent Gene Expression Wash Buffer Kit (Agilent Technologies). Fluorescence signals of the hybridized Agilent Microarrays were detected using Agilent's Microarray Scanner System (Agilent Technologies) and summarized in FES output files.
Data analysis
The intensity data were background corrected, quantile normalized (Bolstad et al., 2003) , and log2 transformed. Transcripts were considered detected in a group, if 50% or more of the samples had a detection p value % 0.05. The log2-transformed fold changes were calculated, p values % 0.05 for differential expression between the compared groups was considered significant. The comparison of Tcon and Treg was done pairwise. For the evaluation of differential expression between allergic and healthy controls, the signal of every sample was compared to the opposite group median.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the definition of center, dispersion and precision measure and statistical significance are reported in the Figures and the Figure Legends . Statistical tests were performed with GraphPad PRISM software 6.0 (GraphPad Software, La Jolla, CA, USA) or R statistical environment. Statistical tests were selected based on appropriate assumptions with respect to data distribution and variance characteristics, p values < 0.05 were considered statistically significant. EC 50 values were calculated from dose-response curves using PRISM, the bottom and top of the curve were defined as 0 and 100, respectively.
DATA AND SOFTWARE AVAILABILITY Software
The TCR diversity analysis was performed using R, version 3.2.2. Ré nyi diversity profiles were calculated using the R package 'vegan', version 2.3-2 (Oksanen et al., 2015) . The Gini coefficients were calculated using the R package 'ineq', version 0.2-13 (Zeileis, 2014) . Our implementation of Yue-Clayton similarity index in R is available upon request.
For read out and process the microarray image files, the Agilent Feature Extraction Software (FES) FES 10.7.3.1 was used. Microarray data analysis was performed using R, version 3.2.1; Platform: i386-w64-mingw32/i386 (32-bit). p values for differential expression were calculated using the R package 'limma' (Ritchie et al., 2015; Smyth, 2004) .
Data Resources
The accession number for the microarray data reported in this paper is GEO: GSE77081. F o o d a n t i g e n s C o m m e n s a l b a c t e r i a A e r oa n t i g e n s I n f e c t i o u s a n t i g e n s + V a c c i n e s B ir c h G r a s s
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